Kodiak Sciences Inc
(FRA:K27)
€
3.546
0.072 (2.07%)
Market Cap: 211.94 Mil
Enterprise Value: 80.00 Mil
PE Ratio: 0
PB Ratio: 0.96
GF Score: 37/100 Kodiak Sciences Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023 / 05:30PM GMT
Release Date Price:
€8.65
(+1.81%)
Mike Yee
Jefferies - Analyst
We are very fortunate to have the CEO of Kodiak up here with us on a fireside chat. Kodiak, if you haven't been paying attention, has major Phase 3 data coming up for their lead program in retinal diseases. And it feels like people are starting to get focused and get engaged, Victor.
Questions & Answers
Mike Yee
Jefferies - Analyst
So I would love for you to maybe just make some opening comments about the state of affairs with your program and what data is coming up. And why you feel excited about where Kodiak is today?
Victor Perlroth
Kodiak Sciences Inc. - Chairman & CEO
Thanks a lot, Mike. Can you hear me?
Mike Yee
Jefferies - Analyst
Yeah.
Victor Perlroth
Kodiak Sciences Inc. - Chairman & CEO
It's a pleasure to be here. Thanks, everyone. See if we have the presentation, too.
Mike Yee
Jefferies - Analyst
And if we if we don't
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot